Women Focused Encounters for Resilience Independence Strength and Eudaimonia
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Jan 11, 2024
Trial Information
Current as of November 11, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Women Focused Encounters for Resilience Independence Strength and Eudaimonia," is designed to help women living with HIV who may also be dealing with issues like substance use, trauma, and challenges sticking to their medication. The study will use a program that combines peer support, acceptance and commitment therapy (ACT), and exercise to see if these elements can help improve how consistently participants take their HIV medications. The trial will take place in four counties and aims to find out if community organizations can continue this program even after the study ends.
To participate in the trial, women must be HIV-positive, able to read and understand English, and willing to engage in a low-intensity exercise program. They should also have a history of missing doses of their HIV medication or have experienced violence in their lives. Participants can expect to receive support from peers and to be involved in activities that promote both mental and physical well-being. Importantly, participants will need to be fully vaccinated against COVID-19 or agree to wear a mask during in-person sessions. This trial not only hopes to improve health outcomes for women but also to empower local organizations to support these women long-term.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Is female sex at birth (cis-women)
- • 2. Able to read and understand English
- • 3. Able to participate in a low intensity exercise program
- • 4. HIV-seropositive
- • 5. At risk substance use (any illegal or unprescribed drug), tobacco, marijuana or alcohol use (four or more drinks in one day or 8 or more in one week).
- • 6. Reports missing more ART doses than previous months, or \> 5 in a month, or has a detectable HIV viral load
- • 7. Experienced interpersonal violence
- • 8. Able and willing to provide informed consent
- • 9. Confirmed COVID-19 vaccinated x 2 or willingness to wear a mask during inperson interactions.
- Exclusion Criteria:
- • 1. Unwilling to participate in video record sessions (used to evaluate the quality of the intervention)
- • 2. Enrolled in hospice
- • 3. Not willing or not able to comply with study advisory board group participation agreement.
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
San Diego, California, United States
Patients applied
Trial Officials
Maile Karris, MD
Principal Investigator
UCSD
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported